Journal
CIRCULATION
Volume 124, Issue 23, Pages E574-E651Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIR.0b013e31823ba622
Keywords
AHA Scientific Statements; acute coronary syndromes; anticoagulants; antiplatelet agents; antiplatelet agents; arrhythmias, cardiac; coronary artery revascularization interventions: stents; coronary angiography; drug therapy; drug delivery systems; heart diseases; myocardial revascularization; platelet aggregation inhibitor; ultrasound
Ask authors/readers for more resources
The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available